Advertisement

Topics

Search Results for "Orthophoenix Llc Medtornic Kyphon Patents"

09:13 EST 8th December 2016 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

BioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative ...

New Patents Supplement Existing Portfolio of More Than 700 Patents and Patent Applications Owned or Licensed by BioTime Family of Companies Worldwide Read more...

Figure: 2 patents, 3 inventors, 4 companies

In the CRISPR tea leaves Strategy 2 patents, 3 inventors, 4 companies The foundational CRISPR patents have undergone a series of licensing transactions, resulting in four companies with different, som...

Figure: 2 patents 3 inventors 4 companies

In the CRISPR tea leaves Strategy 2 patents, 3 inventors, 4 companies The foundational CRISPR patents have undergone a series of licensing transactions, resulting in four companies with different, som...

BRIEF-BORYUNG PHARM announces patents granted

* Says it receives two patents on July 4, for pharmaceutical combination preparation

BioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative Medicine

Monday, August 15th 2016 at 12:00pm UTC New Patents Supplement Existing Portfolio of More Than 700 Patents and Patent Applications Owned or Licensed by BioTime Family of Companies Worldwide ALAMEDA, C...

BRIEF-Suven Life Sciences gets 2 product patents in China, Mexico

* Patents are valid through 2032 and 2031 Further company coverage:

PhRMA Fact Check: The truth about biopharmaceutical patents

The myths and facts around the use of patents by drugmakers are analyzed by Mark Grayson, vice president…

BRIEF-Suven Life Sciences says secures two product patents in Europe and Israel

* Patents corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases

Matching PubMed Articles

Extending the market exclusivity of therapeutic antibodies through dosage patents.

Dosage patents are one way to extend the market exclusivity of an approved drug beyond the lifetime of the patent that protects the drug as such. Dosage patents may help to compensate the applicant fo...

Searching bioremediation patents through Cooperative Patent Classification (CPC).

Patent classification systems have traditionally evolved independently at each patent jurisdiction to classify patents handled by their examiners to be able to search previous patents while dealing wi...

Patent litigation in India continues to throw up new challenges.

For several years after the reinstitution of a pharmaceutical patent regime in India, most innovator pharmaceutical companies have faced a string of high-profile defeats during litigation in India. In...

Big Data from Pharmaceutical Patents: A Computational Analysis of Medicinal Chemists' Bread and Butter.

Multiple recent studies have focused on unraveling the content of the medicinal chemist's toolbox. Here, we present an investigation of chemical reactions and molecules retrieved from US patents over ...

Divided Infringement in the Limelight of the Patent Battle Field.

Diagnostic patents usually comprise multiple steps and can be jointly implemented by different parties. However, in the USA, joint implementation may render diagnostic patents unenforceable in light o...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement